NO20013003D0 - Quinoline derivatives - Google Patents
Quinoline derivativesInfo
- Publication number
- NO20013003D0 NO20013003D0 NO20013003A NO20013003A NO20013003D0 NO 20013003 D0 NO20013003 D0 NO 20013003D0 NO 20013003 A NO20013003 A NO 20013003A NO 20013003 A NO20013003 A NO 20013003A NO 20013003 D0 NO20013003 D0 NO 20013003D0
- Authority
- NO
- Norway
- Prior art keywords
- quinoline derivatives
- quinoline
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9827882.3A GB9827882D0 (en) | 1998-12-17 | 1998-12-17 | Novel compounds |
| PCT/EP1999/009564 WO2000035919A2 (en) | 1998-12-17 | 1999-12-03 | Quinoline derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20013003D0 true NO20013003D0 (en) | 2001-06-15 |
| NO20013003L NO20013003L (en) | 2001-07-25 |
Family
ID=10844468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20013003A NO20013003L (en) | 1998-12-17 | 2001-06-15 | Quinoline derivatives |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1140946A2 (en) |
| JP (1) | JP2002532501A (en) |
| KR (1) | KR20010108028A (en) |
| CN (1) | CN1335850A (en) |
| AU (1) | AU3036000A (en) |
| BR (1) | BR9916307A (en) |
| CA (1) | CA2355234A1 (en) |
| CO (1) | CO5150146A1 (en) |
| CZ (1) | CZ20012151A3 (en) |
| GB (1) | GB9827882D0 (en) |
| HK (1) | HK1041480A1 (en) |
| HU (1) | HUP0104662A2 (en) |
| IL (1) | IL143782A0 (en) |
| NO (1) | NO20013003L (en) |
| PL (1) | PL353156A1 (en) |
| TR (1) | TR200101764T2 (en) |
| WO (1) | WO2000035919A2 (en) |
Families Citing this family (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9926303D0 (en) * | 1999-11-05 | 2000-01-12 | Smithkline Beecham Plc | Novel compounds |
| TWI224101B (en) | 2001-06-20 | 2004-11-21 | Wyeth Corp | Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| DK1397130T3 (en) | 2001-06-20 | 2007-11-12 | Wyeth Corp | Substituted Indole Acid Derivatives as Inhibitors of Plasminogen Activator Inhibitor-1 (PAI-1) |
| EP1844771A3 (en) * | 2001-06-20 | 2007-11-07 | Wyeth | Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| US7084156B2 (en) | 2001-11-27 | 2006-08-01 | Merck & Co., Inc. | 2-Aminoquinoline compounds |
| UA80453C2 (en) | 2002-12-10 | 2007-09-25 | Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1) | |
| ATE430731T1 (en) | 2002-12-10 | 2009-05-15 | Wyeth Corp | SUBSTITUTED INDOLOXOACETYLAMINOACETIC ACID DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) |
| DE60324183D1 (en) | 2002-12-10 | 2008-11-27 | Wyeth Corp | Aryl-, aryloxy- und alkyloxysubstituierte 1h-indol-3-yl-glyoxylsäurederivateals inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1) |
| DK1569899T3 (en) | 2002-12-10 | 2006-10-23 | Wyeth Corp | Substituted 3-alkyl and 3-arylalkyl-1H-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| JP2006514637A (en) | 2002-12-10 | 2006-05-11 | ワイス | Substituted 3-carbonyl-1H-indol-1-ylacetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| US7163954B2 (en) | 2003-09-25 | 2007-01-16 | Wyeth | Substituted naphthyl benzothiophene acids |
| US7332521B2 (en) | 2003-09-25 | 2008-02-19 | Wyeth | Substituted indoles |
| US7446201B2 (en) | 2003-09-25 | 2008-11-04 | Wyeth | Substituted heteroaryl benzofuran acids |
| US7268159B2 (en) | 2003-09-25 | 2007-09-11 | Wyeth | Substituted indoles |
| US7351726B2 (en) | 2003-09-25 | 2008-04-01 | Wyeth | Substituted oxadiazolidinediones |
| US7265148B2 (en) | 2003-09-25 | 2007-09-04 | Wyeth | Substituted pyrrole-indoles |
| US7582773B2 (en) | 2003-09-25 | 2009-09-01 | Wyeth | Substituted phenyl indoles |
| US7442805B2 (en) | 2003-09-25 | 2008-10-28 | Wyeth | Substituted sulfonamide-indoles |
| US7141592B2 (en) | 2003-09-25 | 2006-11-28 | Wyeth | Substituted oxadiazolidinediones |
| JP4503022B2 (en) | 2003-12-23 | 2010-07-14 | ファイザー・インク | New quinoline derivatives |
| UY30892A1 (en) | 2007-02-07 | 2008-09-02 | Smithkline Beckman Corp | AKT ACTIVITY INHIBITORS |
| CN105360132A (en) | 2010-11-03 | 2016-03-02 | 陶氏益农公司 | Pesticidal Compositions and Processes Related Thereto |
| PH12014500930A1 (en) | 2011-10-26 | 2014-06-09 | Dow Agrosciences Llc | Pesticidal compositions and processes related thereto |
| US8901153B2 (en) | 2012-04-27 | 2014-12-02 | Dow Agrosciences, Llc. | Pesticidal compositions and processes related thereto |
| US9708288B2 (en) | 2012-04-27 | 2017-07-18 | Dow Agrosciences Llc | Pesticidal compositions and processes related thereto |
| US9282739B2 (en) | 2012-04-27 | 2016-03-15 | Dow Agrosciences Llc | Pesticidal compositions and processes related thereto |
| US10092574B2 (en) | 2012-09-26 | 2018-10-09 | Valorisation-Recherche, Limited Partnership | Inhibitors of polynucleotide repeat-associated RNA foci and uses thereof |
| JP2016535010A (en) | 2013-10-17 | 2016-11-10 | ダウ アグロサイエンシィズ エルエルシー | Method for producing pest control compound |
| MX2016004940A (en) | 2013-10-17 | 2016-06-28 | Dow Agrosciences Llc | Processes for the preparation of pesticidal compounds. |
| CN105636445B (en) | 2013-10-17 | 2018-12-07 | 美国陶氏益农公司 | Process for preparing pesticidal compounds |
| WO2015058021A1 (en) | 2013-10-17 | 2015-04-23 | Dow Agrosciences Llc | Processes for the preparation of pesticidal compounds |
| CA2925952A1 (en) | 2013-10-17 | 2015-04-23 | Dow Agrosciences Llc | Processes for the preparation of pesticidal compounds |
| EP3057426A4 (en) | 2013-10-17 | 2017-03-29 | Dow AgroSciences LLC | Processes for the preparation of pesticidal compounds |
| CA2925595A1 (en) | 2013-10-17 | 2015-04-23 | Dow Agrosciences Llc | Processes for the preparation of pesticidal compounds |
| EP3062619B1 (en) | 2013-10-22 | 2019-07-24 | Dow AgroSciences LLC | Pesticidal compositions and related methods |
| JP2016535025A (en) | 2013-10-22 | 2016-11-10 | ダウ アグロサイエンシィズ エルエルシー | Synergistic pest control compositions and related methods |
| JP2016538265A (en) | 2013-10-22 | 2016-12-08 | ダウ アグロサイエンシィズ エルエルシー | Synergistic pest control compositions and related methods |
| AU2014340412B2 (en) | 2013-10-22 | 2017-04-20 | Dow Agrosciences Llc | Synergistic pesticidal compositions and related methods |
| JP2016536307A (en) | 2013-10-22 | 2016-11-24 | ダウ アグロサイエンシィズ エルエルシー | Agrochemical compositions and related methods |
| JP2016535024A (en) | 2013-10-22 | 2016-11-10 | ダウ アグロサイエンシィズ エルエルシー | Synergistic pest control compositions and related methods |
| WO2015061163A1 (en) | 2013-10-22 | 2015-04-30 | Dow Agrosciences Llc | Pesticidal compositions and related methods |
| MX2016005310A (en) | 2013-10-22 | 2016-08-08 | Dow Agrosciences Llc | Synergistic pesticidal compositions and related methods. |
| TW201519786A (en) | 2013-10-22 | 2015-06-01 | 陶氏農業科學公司 | Insecticidal composition and related methods (1) |
| NZ719754A (en) | 2013-10-22 | 2017-06-30 | Dow Agrosciences Llc | Synergistic pesticidal compositions and related methods |
| JP2016534068A (en) | 2013-10-22 | 2016-11-04 | ダウ アグロサイエンシィズ エルエルシー | Synergistic pest control compositions and related methods |
| NZ720023A (en) | 2013-10-22 | 2017-09-29 | Dow Agrosciences Llc | Synergistic pesticidal compositions and related methods |
| KR20160074640A (en) | 2013-10-22 | 2016-06-28 | 다우 아그로사이언시즈 엘엘씨 | Pesticidal compositions and related methods |
| CA2926433A1 (en) | 2013-10-22 | 2015-04-30 | Dow Agrosciences Llc | Pesticidal compositions and related methods |
| EP3060050A4 (en) | 2013-10-22 | 2017-04-05 | Dow AgroSciences LLC | Synergistic pesticidal compositions and related methods |
| KR20160074581A (en) | 2013-10-22 | 2016-06-28 | 다우 아그로사이언시즈 엘엘씨 | Synergistic pesticidal compositions and related methods |
| NZ719541A (en) | 2013-10-22 | 2017-11-24 | Dow Agrosciences Llc | Synergistic pesticidal compositions and related methods |
| CN106488909A (en) | 2014-07-31 | 2017-03-08 | 美国陶氏益农公司 | The method for preparing 3 (3 chlorine 1H pyrazoles, 1 base) pyridine |
| KR20170039121A (en) | 2014-07-31 | 2017-04-10 | 다우 아그로사이언시즈 엘엘씨 | Process for the preparation of 3-(3-chloro-1h-pyrazol-1-yl)pyridine |
| JP2017523168A (en) | 2014-07-31 | 2017-08-17 | ダウ アグロサイエンシィズ エルエルシー | Method for producing 3- (3-chloro-1H-pyrazol-1-yl) pyridine |
| KR20170042714A (en) | 2014-08-19 | 2017-04-19 | 다우 아그로사이언시즈 엘엘씨 | Process for the preparation of 3-(3-chloro-1h-pyrazol-1-yl)pyridine |
| JP2017528469A (en) | 2014-09-12 | 2017-09-28 | ダウ アグロサイエンシィズ エルエルシー | Method for preparing 3- (3-chloro-1H-pyrazol-1-yl) pyridine |
| BR112019008372B1 (en) | 2016-12-29 | 2021-11-09 | Dow Agrosciences Llc | PROCESS FOR PREPARATION OF PESTICIDES COMPOUNDS |
| WO2018125817A1 (en) | 2016-12-29 | 2018-07-05 | Dow Agrosciences Llc | Processes for the preparation of pesticidal compounds |
| CN108570450A (en) * | 2017-03-11 | 2018-09-25 | 华中科技大学鄂州工业技术研究院 | A kind of application of cell model and its construction and screening Serotonin receptor target active substance |
| CN106883192B (en) * | 2017-03-30 | 2019-05-14 | 苏州汉德创宏生化科技有限公司 | The synthetic method of the benzoic acid derivative of nitrogenous class heterocyclic antineoplastic pharmaceutical actives oxazolyl modification |
| CA3179333A1 (en) * | 2020-04-03 | 2021-10-07 | Vertex Pharmaceuticals Incorporated | Modulators of alpha-1 antitrypsin |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995006644A1 (en) * | 1993-09-03 | 1995-03-09 | Smithkline Beecham Plc | Amide derivatives as 5ht1d receptor antagonists |
| PL336317A1 (en) * | 1997-04-18 | 2000-06-19 | Smithkline Beecham Plc | Derivatives of indole exhibiting combined activity of receptor 5ht 1a, 5ht and 5ht 1d antagonist |
| WO1998047868A1 (en) * | 1997-04-18 | 1998-10-29 | Smithkline Beecham Plc | Heterocycle-containing urea derivatives as 5ht1a, 5ht1b and 5ht1d receptor antagonists |
| EP1047691A1 (en) * | 1997-12-12 | 2000-11-02 | Smithkline Beecham Plc | Quinolinepiperazine and quinolinepiperidine derivatives, their preparation and their use as combined 5-ht1a, 5-ht1b and 5-ht1d receptor antagonists |
-
1998
- 1998-12-17 GB GBGB9827882.3A patent/GB9827882D0/en not_active Ceased
-
1999
- 1999-12-03 PL PL99353156A patent/PL353156A1/en not_active Application Discontinuation
- 1999-12-03 TR TR2001/01764T patent/TR200101764T2/en unknown
- 1999-12-03 EP EP99964526A patent/EP1140946A2/en not_active Withdrawn
- 1999-12-03 CN CN99816080A patent/CN1335850A/en active Pending
- 1999-12-03 KR KR1020017007626A patent/KR20010108028A/en not_active Withdrawn
- 1999-12-03 WO PCT/EP1999/009564 patent/WO2000035919A2/en not_active Ceased
- 1999-12-03 BR BR9916307-1A patent/BR9916307A/en not_active Application Discontinuation
- 1999-12-03 JP JP2000588178A patent/JP2002532501A/en active Pending
- 1999-12-03 HK HK02101212.8A patent/HK1041480A1/en unknown
- 1999-12-03 AU AU30360/00A patent/AU3036000A/en not_active Abandoned
- 1999-12-03 HU HU0104662A patent/HUP0104662A2/en unknown
- 1999-12-03 CA CA002355234A patent/CA2355234A1/en not_active Abandoned
- 1999-12-03 IL IL14378299A patent/IL143782A0/en unknown
- 1999-12-03 CZ CZ20012151A patent/CZ20012151A3/en unknown
- 1999-12-17 CO CO99078949A patent/CO5150146A1/en unknown
-
2001
- 2001-06-15 NO NO20013003A patent/NO20013003L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU3036000A (en) | 2000-07-03 |
| CN1335850A (en) | 2002-02-13 |
| WO2000035919A3 (en) | 2000-10-26 |
| CZ20012151A3 (en) | 2001-12-12 |
| JP2002532501A (en) | 2002-10-02 |
| PL353156A1 (en) | 2003-10-20 |
| EP1140946A2 (en) | 2001-10-10 |
| HUP0104662A2 (en) | 2002-04-29 |
| CA2355234A1 (en) | 2000-06-22 |
| IL143782A0 (en) | 2002-04-21 |
| NO20013003L (en) | 2001-07-25 |
| TR200101764T2 (en) | 2001-10-22 |
| KR20010108028A (en) | 2001-12-07 |
| WO2000035919A2 (en) | 2000-06-22 |
| HK1041480A1 (en) | 2002-07-12 |
| CO5150146A1 (en) | 2002-04-29 |
| BR9916307A (en) | 2002-01-15 |
| GB9827882D0 (en) | 1999-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20013003D0 (en) | Quinoline derivatives | |
| ATE250036T1 (en) | QUINOLINE DERIVATIVES | |
| ATE228505T1 (en) | QUINOLINE DERIVATIVES | |
| ATE229005T1 (en) | QUINOLINE DERIVATIVES | |
| DK1140935T3 (en) | 1,2-celled quinoline derivatives | |
| NO20010193D0 (en) | Tiobenzimidazol derivatives | |
| ATE236136T1 (en) | BENZOSULFONE DERIVATIVES | |
| DE69934788D1 (en) | BIOZIDE BENZYLBIPHENYL DERIVATIVE | |
| NO20010514D0 (en) | Aminometylkarboksylsyre derivatives | |
| ATE259810T1 (en) | PHENYL-XANTHINE DERIVATIVES | |
| DK1115716T3 (en) | 2-phenylpyran-4-one derivatives | |
| PT1056716E (en) | CYCLOHEXANODIOL DERIVATIVES | |
| DK1134219T3 (en) | Cucloalkyl-substituted aminomethylpyrrolidine derivatives | |
| ATE233253T1 (en) | CHROMEDER DERIVATIVES | |
| ATE281436T1 (en) | QUINOLINE-4-YL DERIVATIVES | |
| DK1060183T3 (en) | 5-deoxycytidine derivatives | |
| PT1123283E (en) | TIAZOLE DERIVATIVES | |
| DE59907635D1 (en) | PYRAZOLYLDIOXOTHIOCHROMANOYL DERIVATIVES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |